These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
4. Rational vaccine development--a new trend in tuberculosis control. Kaplan G N Engl J Med; 2005 Oct; 353(15):1624-5. PubMed ID: 16221789 [No Abstract] [Full Text] [Related]
5. Immunoprophylaxis of tuberculosis: an update of emerging trends. Singhal N; Bisht D; Joshi B Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):97-106. PubMed ID: 20140756 [TBL] [Abstract][Full Text] [Related]
6. The use of mutant mycobacteria as new vaccines to prevent tuberculosis. Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875 [TBL] [Abstract][Full Text] [Related]
7. [Search for new tuberculosis vaccines]. Gicquel B Bull Acad Natl Med; 1999; 183(7):53-61; discussion 61-2. PubMed ID: 10622122 [TBL] [Abstract][Full Text] [Related]
8. New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development. Kamath AT; Fruth U; Brennan MJ; Dobbelaer R; Hubrechts P; Ho MM; Mayner RE; Thole J; Walker KB; Liu M; Lambert PH; ; Vaccine; 2005 May; 23(29):3753-61. PubMed ID: 15893612 [TBL] [Abstract][Full Text] [Related]
9. Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine. Comstock GW Clin Infect Dis; 2000 Jun; 30 Suppl 3():S250-3. PubMed ID: 10875793 [TBL] [Abstract][Full Text] [Related]
10. Mouse and guinea pig models for testing new tuberculosis vaccines. Orme IM Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022 [TBL] [Abstract][Full Text] [Related]
13. [An experimental analysis of Mycobacterium smegmatis as a possible vector for the design of a new tuberculosis vaccine]. Eremeev VV; Maiorov KB; Avdienko VG; Kondrashov SIu; Apt AS Probl Tuberk; 1996; (1):49-51. PubMed ID: 8907489 [TBL] [Abstract][Full Text] [Related]
15. Mycobacterium-specific human CD8 T cell responses. Klein MR; Fox A Arch Immunol Ther Exp (Warsz); 2001; 49(5):379-89. PubMed ID: 11798136 [TBL] [Abstract][Full Text] [Related]
16. Clinical considerations in designing trials of vaccines for tuberculosis. Glassroth J Clin Infect Dis; 2000 Jun; 30 Suppl 3():S229-32. PubMed ID: 10875789 [TBL] [Abstract][Full Text] [Related]
17. Development of live recombinant vaccine candidates against tuberculosis. Hess J; Kaufmann SH Scand J Infect Dis; 2001; 33(10):723-4. PubMed ID: 11728033 [TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
19. New strategies against an old plague: genetically engineered tuberculosis vaccines. Dreher D; Kok M; Pechère JC; Nicod LP Schweiz Med Wochenschr; 2000 Dec; 130(50):1925-9. PubMed ID: 11189437 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis: from genome to vaccine. de Jonge MI; Brosch R; Brodin P; Demangel C; Cole ST Expert Rev Vaccines; 2005 Aug; 4(4):541-51. PubMed ID: 16117711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]